Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Renal rehabilitation with low-dialysate-flow daily hemodialysis for people on hemodialysis

Official title: Benefits of a Renal Rehabilitation Program Adapted to Uremic Patients on Daily Hemodialysis at Low Dialysate Flow Rate.

Run by Brugmann University Hospital · NCT07413315 · Data updated 2026-11-12

This tests whether combining a tailored rehab program (exercise + nutrition) with low-dialysate-flow daily hemodialysis helps people on hemodialysis who are at risk of muscle loss (sarcopenia).

More Sarcopenia trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorBrugmann University Hospital
Academic / other
Locations1 site (Brussels)
StatusRecruiting
StartedAugust 13, 2024
Main results expectedDecember 31, 2027
Study endsDecember 31, 2027
Registry record updatedFebruary 17, 2026
Trial IDNCT07413315 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with end-stage CKD who require ongoing hemodialysis and are recently hospitalized but medically stable without major cardiac, cognitive, or neurologic contraindications.

Probably not a fit

Patients with significant cognitive impairment, unstable or severe cardiac disease, certain acute infections or inflammatory cardiac conditions, pregnancy, recovery of kidney function, or recent spinal cord injury are unlikely to be eligible or to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional program pairs a multidisciplinary renal rehabilitation plan (structured physical exercise and nutritional monitoring) with low-dialysate-flow hemodialysis delivered more frequently. It targets patients with end-stage chronic kidney disease on hemodialysis, a group with high rates of sarcopenia and post-dialysis symptoms. Eligible participants are recently hospitalized but must be medically stable and free of major cognitive, cardiac, or neurologic contraindications. The study site is CHU Brugmann in Brussels and outcomes are expected to include changes in muscle mass, functional capacity, and dialysis tolerance.

Why it matters

Potential benefit: If successful, the approach could improve muscle strength and physical function, reduce post-dialysis symptoms, and improve quality of life for people on hemodialysis.

How similar studies have gone: Previous work on intradialytic exercise and multidisciplinary renal rehabilitation has shown improvements in physical function and sarcopenia in dialysis populations, though combining these programs with low-dialysate-flow daily hemodialysis is less well studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* patient with terminal chronic kidney disease requiring hemodialysis treatment
* patient recently hospitalized for an acute medical event.

Exclusion Criteria:

* dementia/mild cognitive impairment (MMSE \< 20/30)
* decompensated psychiatric pathology and/or behavioral disorders
* pregnant woman
* recovery of renal function allowing interruption of helodialysis sessions
* candidate for neurological rehabilitation
* patient with recent spinal cord injury
* patient with absolute and/or relative contraindication to performing a stress test
* severe or poorly tolerated cardiac rhythm disorder
* severe or symptomatic obstruction to left ventricular ejection
* decompensated heart failure
* acute myocarditis, pericarditis or endocarditis
* acute aortic dissection
* high-risk emboligenic intracardiac thrombus
* significant stenosis of the common trunk
* ventricular aneurysm
* supraventricular tachycardia with poorly controlled ventricular rate, acquired high-degree or complete block
* obstructive cardiomyopathy with high resting gradient
* recent stroke or TIA
* acute venous thrombosis with or without pulmonary embolism
* poorly controlled clinical condition, such as marked anemia, significant electrolyte disturbance, hyperthyroidism, etc.
* lack of cooperation from the patient
* Blood pressure \> 200/110 mmHg

Where it's running

  • CHU Brugmann
    Brussels, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.